Jon Wertheim: Is that really your sense of self still these days
According to the available evidence, it would be clinically useful to follow a stepwise approach to antidiabetic treatment in patients with NAFLD
Yet while reducing cardiovascular disease by treating high cholesterol, high blood pressure, and diabetes is standard practice, the concept of treating obesity to reduce cardiovascular complications has been hampered by the lack of evidence that lifestyle or pharmacologic interventions for overweight or obesity improve cardiovascular outcomes, said Michael Lincoff, M.D., SELECTs lead author and vice chair for research in Cleveland Clinics Department of Cardiovascular Medicine
Their effectiveness in managing blood sugar and promoting weight loss is not in question, yet a nearly 40% gap separates how doctors rate GLP-1 efficacy from their accessibilityunderscoring a deep disconnect between what a drug can do and whether patients can actually get it
Best practices include removing medication from refrigeration 2030 minutes before injection, visually inspecting for particles or discoloration, and choosing injection sites that rotate to avoid tissue damage
Benefits: Beta-glucan is a soluble fiber that promotes the release of GLP-1 and PYY, improving satiety and blood sugar regulation
